T. Liloglou et al., DETECTION OF THE EPSTEIN-BARR-VIRUS BY THE POLYMERASE CHAIN-REACTION IN IMMUNOSUPPRESSED AND IMMUNOCOMPROMISED PATIENTS, Oncology Reports, 1(4), 1994, pp. 809-811
DNA extracted from the blood of immunosuppressed and immunocompromised
individuals and from patients with infectious mononucleosis, leukaemi
as and lymphomas were studied using the Polymerase Chain Reaction (PCR
) technique. The oligonucleotide primers used for the detection of the
Epstein-Barr virus (EBV) amplify a 375bp sequence from the EcoRI B fr
agment of the viral genome. EBV specific sequences were amplified from
the blood samples of 18 out of 65 patients, most of which were transp
lant patients (9 out of 31). The results confirmed the association of
EBV with clinical disorders in immunodeficient and immunocompromised p
atients and the importance of PCR method in routine diagnosis.